| Period Ending | Dec 30, 2012 | Dec 30, 2011 |
|---|
|
Total Revenue
|
1,999,000
|
3,024,000
| | Cost of Revenue | 1,201,000 | 1,600,000 | | |
Gross Profit
|
798,000
|
1,424,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
|
Selling General and Administrative | 414,000 | 396,000 |
|
Non Recurring |
-
| 2,000 |
|
Others | 58,000 | 69,000 |
|
|
|
Total Operating Expenses |
-
|
-
| | | |
Operating Income or Loss
|
326,000
|
957,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 373,000 | 142,000 |
|
Earnings Before Interest And Taxes | 2,045,000 | 1,186,000 |
|
Interest Expense | 33,000 | 21,000 |
|
Income Before Tax | 2,012,000 | 1,165,000 |
|
Income Tax Expense | 600,000 | 333,000 |
|
Minority Interest | 2,000 | 4,000 |
|
|
|
Net Income From Continuing Ops | 2,760,000 | 923,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
|
Extraordinary Items |
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
|
Other Items |
-
|
-
| | | |
Net Income
|
1,414,000
|
836,000
| | Preferred Stock And Other Adjustments |
-
|
-
| | |
Net Income Applicable To Common Shares
|
1,414,000
|
836,000
|
|